Form 8-K - Current report:
SEC Accession No. 0001193125-25-005011
Filing Date
2025-01-13
Accepted
2025-01-13 08:06:36
Documents
48
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d923845d8k.htm   iXBRL 8-K 26433
2 EX-99.1 d923845dex991.htm EX-99.1 44929
6 GRAPHIC g923845ex99_1p10g1.jpg GRAPHIC 389850
7 GRAPHIC g923845ex99_1p11g1.jpg GRAPHIC 343322
8 GRAPHIC g923845ex99_1p12g1.jpg GRAPHIC 220526
9 GRAPHIC g923845ex99_1p13g1.jpg GRAPHIC 295004
10 GRAPHIC g923845ex99_1p14g1.jpg GRAPHIC 331405
11 GRAPHIC g923845ex99_1p15g1.jpg GRAPHIC 192850
12 GRAPHIC g923845ex99_1p16g1.jpg GRAPHIC 335581
13 GRAPHIC g923845ex99_1p17g1.jpg GRAPHIC 220227
14 GRAPHIC g923845ex99_1p18g1.jpg GRAPHIC 230473
15 GRAPHIC g923845ex99_1p19g1.jpg GRAPHIC 209596
16 GRAPHIC g923845ex99_1p1g1.jpg GRAPHIC 265148
17 GRAPHIC g923845ex99_1p20g1.jpg GRAPHIC 231302
18 GRAPHIC g923845ex99_1p21g1.jpg GRAPHIC 254966
19 GRAPHIC g923845ex99_1p22g1.jpg GRAPHIC 281212
20 GRAPHIC g923845ex99_1p23g1.jpg GRAPHIC 316335
21 GRAPHIC g923845ex99_1p24g1.jpg GRAPHIC 307522
22 GRAPHIC g923845ex99_1p25g1.jpg GRAPHIC 350500
23 GRAPHIC g923845ex99_1p26g1.jpg GRAPHIC 344998
24 GRAPHIC g923845ex99_1p27g1.jpg GRAPHIC 212036
25 GRAPHIC g923845ex99_1p28g1.jpg GRAPHIC 295816
26 GRAPHIC g923845ex99_1p29g1.jpg GRAPHIC 247238
27 GRAPHIC g923845ex99_1p2g1.jpg GRAPHIC 677846
28 GRAPHIC g923845ex99_1p30g1.jpg GRAPHIC 294212
29 GRAPHIC g923845ex99_1p31g1.jpg GRAPHIC 280698
30 GRAPHIC g923845ex99_1p32g1.jpg GRAPHIC 275360
31 GRAPHIC g923845ex99_1p33g1.jpg GRAPHIC 372679
32 GRAPHIC g923845ex99_1p34g1.jpg GRAPHIC 382709
33 GRAPHIC g923845ex99_1p3g1.jpg GRAPHIC 519368
34 GRAPHIC g923845ex99_1p4g1.jpg GRAPHIC 339777
35 GRAPHIC g923845ex99_1p5g1.jpg GRAPHIC 377249
36 GRAPHIC g923845ex99_1p6g1.jpg GRAPHIC 266929
37 GRAPHIC g923845ex99_1p7g1.jpg GRAPHIC 306639
38 GRAPHIC g923845ex99_1p8g1.jpg GRAPHIC 245518
39 GRAPHIC g923845ex99_1p9g1.jpg GRAPHIC 297721
  Complete submission text file 0001193125-25-005011.txt   14689636

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20250113.xsd EX-101.SCH 2868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20250113_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20250113_pre.xml EX-101.PRE 10824
50 EXTRACTED XBRL INSTANCE DOCUMENT d923845d8k_htm.xml XML 3507
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 25524912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)